- - -
Insulinitis (old name: type 1 diabetes), the
overwhelming cause in most (but not all)
cases is an autoimmune attack on beta
cells, said attack which destroys all -or-
close to all insulin production. In some
with Insulinitis, other causes (like severe
pancreatitis, pancreatic cancer, or pan-
creatic wound) can cause the loss of
all or almost all insulin production.
For most with Insulinitis, the following
may deactivate the autoimmune attack,
if it works in humans as well as it has
in animal models. If so, it could act as
a preventative -and- it's unclear the
extent to which other measures would
be needed to restore beta cells once
the autoimmune attack has been muted.
In any case, for those with the autoim-
mune caused type of Insulinitis, CD52
may become a critical part of stopping
the autoimmune attack, and a key part
of any cure which enables a restora-
tion of insulin production in those who
lost their insulin production due to an
autoimmune attack.
- - -
May 20, 2013
http://medicalxpress.com/news/2013-05-immune-protein-diabetes-tracks.html
- - -
Excerpts [with inserts, not part of original
article, included in brackets]:
... Professor Harrison said CD52 held great
promise as a therapeutic agent for preventing
and treating autoimmune diseases such as
... [Insulinitis].
"Immune suppression by CD52 is a previously
undiscovered mechanism that the body uses
to regulate itself, and protect itself against
excessive or damaging immune responses,"
Professor Harrison said.
"We are excited about the prospect of devel-
oping this discovery to clinical trials as soon
as possible, to see if CD52 can be used to
prevent and treat ... [Insulinitis] and other
autoimmune diseases.
...
CD52 appears to play a dominant role in con-
trolling or suppressing immune activity in the
early stages of the immune response, Profes-
sor Harrison said. "We identified a specialised
population of immune cells (T cells) that carry
high levels of CD52, which they release to
dampen the activity of other T cells and pre-
vent uncontrolled immune responses," Profes-
sor Harrison said.
"The cells act as an early 'braking' mechanism."
Professor Harrison said his goal is to prevent
and ultimately cure ... [Insulinitis]. "In animal
models we can prevent and cure ... [Insulinitis],"
Professor Harrison said. "I am hopeful that
these results will be translatable into humans,
hopefully in the not-too-distant future."
...
- - -
Dr. Harrison Video on CD52
(2 minutes, 41 seconds)
http://www.youtube.com/watch?v=IwtphdQL6co
- - -
- - - end excerpts - - -
- - - - - - - - - - - - - - - - - - - -
- - -
Pro-Humanist FREELOVER
C.ure I.nsulinitis A.ssociation
http://prohuman.net/cureinsulinitisassociation.htm
- - -